GGrantIndex
← Leaderboards

Daniel Patrick Regan

Colorado State University

$2,177,619
Attributed
$2,777,735
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $923.1K · FY201625
$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$2,777,735 · 4

By mechanism

T32$1,200,233 · 1
K01$720,161 · 1
R37$629,341 · 1
R03$228,000 · 1

Top collaborators

Others in their field

Top investigators on “Fibroblasts

Research focus

FibroblastsResponseNeoplastic CellMediatingLungLung MetastaticPhenotypeNeoplasm MetastasisMalignant NeoplasmsCellsTumorStromal CellsCell TypeSiteMolecularCytokineMetastatic Neoplasm To The LungPreventBaseInvestigationProteinsMortalityRecurrencePharmaceutical Preparations

Grant awards (13)

Focal Adhesion Kinase inhibition for dual targeting of osteosarcoma cells and the tumor microenvironment to prevent metastasis$629,341
R37 · FY2025 · CA · contact PI
Dual-Degree Medical Scientist Training Program for Veterinarians$293,725
T32 · FY2025 · GM · contact PI
Dual-Degree Medical Scientist Training Program for Veterinarians$330,042
T32 · FY2024 · GM · contact PI
Dual-Degree Medical Scientist Training Program for Veterinarians$348,321
T32 · FY2023 · GM · contact PI
Dual-Degree Medical Scientist Training Program for Veterinarians$228,145
T32 · FY2022 · GM · contact PI
Alveolar Macrophages as Sentinels of Osteosarcoma Pulmonary Micro-Metastasis$114,000
R03 · FY2021 · OD · contact PI
Elucidating the role and regulation of periostin in therapy-induced chemoresistance in metastatic breast cancer$102,951
K01 · FY2021 · OD · contact PI
Elucidating the role and regulation of periostin in therapy-induced chemoresistance in metastatic breast cancer$123,442
K01 · FY2020 · OD · contact PI
Alveolar Macrophages as Sentinels of Osteosarcoma Pulmonary Micro-Metastasis$114,000
R03 · FY2020 · OD · contact PI
Elucidating the role and regulation of periostin in therapy-induced chemoresistance in metastatic breast cancer$123,442
K01 · FY2019 · OD · contact PI
Elucidating the role and regulation of periostin in therapy-induced chemoresistance in metastatic breast cancer$123,442
K01 · FY2018 · OD · contact PI
Elucidating the role and regulation of periostin in therapy-induced chemoresistance in metastatic breast cancer$123,442
K01 · FY2017 · OD · contact PI
Elucidating the role and regulation of periostin in therapy-induced chemoresistance in metastatic breast cancer$123,442
K01 · FY2016 · OD · contact PI